Slate Medicines Appoints Kenneth Koblan as Chief Scientific Officer
Position
Chief Scientific Officer
Company
Slate Medicines
Description
Slate Medicines Inc. has announced the appointment of Kenneth Koblan, PhD, as Chief Scientific Officer. Dr
Quick answer
Slate Medicines Appoints Kenneth Koblan as Chief Scientific Officer (September 14, 2026). Slate Medicines is based in Raleigh, North Carolina, United States.
- Who is the new Chief Scientific Officer at Slate Medicines?
- Slate Medicines named Kenneth Koblan Chief Scientific Officer, announced September 14, 2026.
- What did Slate Medicines announce on September 14, 2026?
- Slate Medicines Inc. has announced the appointment of Kenneth Koblan, PhD, as Chief Scientific Officer.
- Where did Kenneth Koblan work before joining Slate Medicines?
- Kenneth Koblan joins from Vesalius Therapeutics.
- What does Slate Medicines do?
- Slate Medicines, Inc. is a biotech company focused on advancing next generation therapeutics for migraine and other headache disorders.
- Where is Slate Medicines based?
- Slate Medicines is based in Raleigh, North Carolina, United States.
Source: Fundz verified event record.
Who to call at Slate Medicines, and when
A new leader at Slate Medicines brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Slate Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Slate Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Slate Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Slate Medicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Slate Medicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.